Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nab-paclitaxel”

708 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 708 results

Early research (Phase 1)Study completedNCT02020707
What this trial is testing

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Who this might be right for
Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more
Mayo Clinic 43
Testing effectiveness (Phase 2)Study completedNCT04548440
What this trial is testing

Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC Patients

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-Sen University Cancer Center 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT00609791
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT02810418
What this trial is testing

Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors

Who this might be right for
NeoplasmsPancreatic Neoplasms
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)UnknownNCT06235918
What this trial is testing

Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomasResectable Head and Neck Squamous-cell Carcinoma
Xiang Lu 30
Not applicableUnknownNCT05831553
What this trial is testing

TIP in Patients Affected by Metastatic TNBC

Who this might be right for
Metastatic Triple-negative Breast Cancer
Fondazione per la Medicina Personalizzata 100
Early research (Phase 1)UnknownNCT04258072
What this trial is testing

Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma.

Who this might be right for
Pancreas Cancer
Samsung Medical Center 24
Testing effectiveness (Phase 2)UnknownNCT04077983
What this trial is testing

Nab-Paclitaxel Combined With Gemcitabine Adjuvant Chemotherapy After Radical Resection of Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Shanghai Zhongshan Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00729612
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Greg Otterson 63
Testing effectiveness (Phase 2)Looking for participantsNCT06165900
What this trial is testing

Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC

Who this might be right for
Stereotactic RadiotherapyImmunotherapyBreast Cancer
Shengjing Hospital 136
Testing effectiveness (Phase 2)Study completedNCT02767557
What this trial is testing

Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients

Who this might be right for
Unresectable Pancreatic Carcinoma
Herlev Hospital 147
Testing effectiveness (Phase 2)Study completedNCT03579771
What this trial is testing

Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer

Who this might be right for
Resectable CholangiocarcinomaStage IB Intrahepatic Cholangiocarcinoma AJCC v8Stage II Intrahepatic Cholangiocarcinoma AJCC v8+3 more
Emory University 30
Early research (Phase 1)Active Not RecruitingNCT02336087
What this trial is testing

Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery

Who this might be right for
Pancreatic AdenocarcinomaUnresectable Pancreatic CarcinomaStage III Pancreatic Cancer AJCC v6 and v7+1 more
City of Hope Medical Center 21
Testing effectiveness (Phase 2)Study completedNCT05673811
What this trial is testing

Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaMetastatic
Theriva Biologics SL 112
Testing effectiveness (Phase 2)Study completedNCT01839487
What this trial is testing

PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Halozyme Therapeutics 279
Testing effectiveness (Phase 2)UnknownNCT03959397
What this trial is testing

Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer

Who this might be right for
Breast Cancer Stage
Jilin University 250
Early research (Phase 1)Study completedNCT00983424
What this trial is testing

Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Northwestern University 14
Large-scale testing (Phase 3)Study completedNCT04085276
What this trial is testing

Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment

Who this might be right for
Triple-Negative Breast Cancer
Shanghai Junshi Bioscience Co., Ltd. 531
Large-scale testing (Phase 3)Study completedNCT03976362
What this trial is testing

Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)

Who this might be right for
Carcinoma, Squamous Cell, Non-small-cell Lung
Merck Sharp & Dohme LLC 851
Not applicableUnknownNCT04443036
What this trial is testing

Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ Carcinoma

Who this might be right for
Gastric Carcinoma
China Medical University, China 44
Next Page